Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
Study NCT ID:
NCT00974233
Status:
COMPLETED
Last Update Posted:
2019-12-02
First Post:
2009-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-09
First Submit QC Date:
None
Study First Post Date:
2009-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-17
Results First Submit QC Date:
None
Results First Post Date:
2017-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-12-02
Last Update Post Date Type:
ACTUAL